In addition, CDKN2A is a susceptibility gene for head and neck squamous cell carcinoma (HNSCC), lung cancer, esophageal cancer, neural system cancer, breast carcinoma, and sarcomas [217]. This evidence concerns the gene CDKN2A and breast carcinoma.